(Q72194401)
Statements
Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins (English)
Baker D
Butler D
Scallon BJ
O'Neill JK
Turk JL
1 September 1994